Pharmacological analysis of CCK2 receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK2 receptor

Regulatory Peptides

Volumn 103, Issue 1, 2002, Pages 29-37

  Nilsson, Isabelle ^a   Monstein, Hans Jürg ^a   Lindström, Erik ^b   Håkanson, Rolf ^b   Svensson, Samuel ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

CCK B gastrin receptor; CCK B gastrin receptor ligand; CCK2 receptor; CCK2 receptor ligand; Human

Indexed keywords

1 (2,2 DIETHOXYETHYL) 3 [(4 METHYLPHENYL)AMINOCARBONYLMETHYL] 3 [(4 METHYLPHENYL)UREIDO]INDOLINE 2 ONE; 1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 2 OXO 1 PIVALOYLMETHYL 5 (2 PYRIDYL) 1H 1,4 BENZODIAZEPIN 3 YL] 3 [3 (METHYLAMINO)PHENYL]UREA; 1 [5 (3 AZABICYCLO[3.2.2]NON 3 YL) 2,3 DIHYDRO 1 METHYL 2 OXO 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; 4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; 4 [[2 [[3 (1H INDOL 3 YL) 2 METHYL 1 OXO 2 [[(TRICYCLO[3.31.1 3,7]DEC 2 YLOXY)CARBONYL]AMINO]PROPYL]AMINO] 1 PHENYLETHYL]AMINO] 4 OXOBUTENOIC ACID; 5 [2,5 DIAZA 5 (3,5 DICARBOXYPHENYL) 1,4 DIOXO 3 METHYLPHENYLPENTANYL] 6 [3 (1 ADAMANTYL) 2 AZA 1 OXOPROPYL]INDOLE BIS N METHYL DEXTRO GLUCAMINE; 6 [[(1 ADAMANTYLMETHYL)AMINO]CARBONYL] 5 [[1 [[(3,5 DICARBOXYPHENYL)AMINO]CARBONYL] 2 PHENYLETHYLAMINO]CARBONYL]INDOLE; AG 041R; CHOLECYSTOKININ RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE DERIVATIVE; GUANYLYLIMIDODIPHOSPHATE; LIGAND; PD 136450; RADIOLIGAND; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CELL MEMBRANE; CELL STRAIN; CONTROLLED STUDY; INCUBATION TIME; LIGAND BINDING; MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CELL LINE; CELL MEMBRANE; COS CELLS; GENE EXPRESSION; GUANOSINE TRIPHOSPHATE; HUMANS; KINETICS; LIGANDS; MODELS, THEORETICAL; NEUROBLASTOMA; RADIOLIGAND ASSAY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CELL SURFACE; RECEPTORS, CHOLECYSTOKININ; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037079863     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(01)00324-X     Document Type: Article

References (40)

1. Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression, and chromosomal localization
2. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas
3. Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression
4. G protein-coupled receptors in gastrointestinal physiology: I. CCK receptors: An exemplary family
5. International union of pharmacology: XXI. Structure, distribution, and functions of cholecystokinin receptors
6. Functional characterization of two cholecystokinin-B/gastrin receptor isoforms: A preferential splice donor site in the human receptor gene
7. Gastrin receptors on isolated canine parietal cells
8. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion
9. Gastric acid secretion after depletion of enterochromaffin-like cell histamine. A study with alpha-fluoromethylhistidine in rats
10. Gastric submucosal microdialysis: A method to study gastrin-and food-evoked mobilization of ECL-cell histamine in conscious rats
11. CCK-B receptor: Chemistry, molecular biology, biochemistry and pharmacology
12. CCK2 receptor antagonists: Pharmacological tools to study the gastrin-ECL cell-parietal cell axis
13. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo
14. Characterization of cloned human cholecystokinin-B receptor as a gastrin receptor
15. YM022 [(R)-1-[2,3-dihydro-1-(2(-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: An irreversible cholecystokinin type-B receptor antagonist
16. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2(-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo
17. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo
18. Pharmacological profile of AG041R. A novel selective gastrin/CCK-B antagonist
19. Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic heteroaromatic skeletons
20. Development of a class of selective cholecystokinin type B receptor antagonists having a potent anxiolytic activity
21. Rationally designed 'dipeptoid' analogues of CCK. α-Methyl-tryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties
22. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase
23. Cloning and characterization of 5′-end alternatively spliced human cholecystokinin-B receptor mRNAs
24. Cloning and expression of a fish alpha 2-adrenoceptor
25. 3H]L-365,260: A new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand
26. Radioligand binding methods: Practical guide and tips
27. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
28. Multiple affinity states of different cholecystokinin receptors
29. Roques Synthesis and biological properties of new constrained CCK-B antagonists: Discrimination of two affinity states of the CCK-B receptor on transfected CHO cells
30. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): Evidence for CCK-B receptor heterogeneity
31. B subsites
32. G protein-coupled receptors: II. Mechanism of agonist activation
33. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones
34. Purification of unique alpha subunits of GTP-binding regulatory proteins (G proteins) by affinity chromatography with immobilized beta gamma subunits
35. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex
36. Functional significance of potential splice variants of the human cholecystokinin (CCK) B receptor
37. The human gastrin/cholecystokinin type B receptor gene: Alternative splice donor site in exon 4 generates two variant mRNAs
38. Functional differences between full and partial agonists: Evidence for ligand-specific receptor conformations
39. Divergent proliferative responses to a gastrin receptor ligand in synchronized and unsynchronized rat pancreatic AR42J tumour cells
40. Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor